Journal: ACS synthetic biology
Article Title: The Impact of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells
doi: 10.1021/acssynbio.5b00299
Figure Lengend Snippet: Cas9 editing efficiencies at target sites in unsilenced, partially silenced, and fully silenced chromatin states. (a) A map of the Cas9/sgRNA-expressing plasmid. Cas9 and EGFP expression are both driven by the CBh promoter. The T2A signal allows EGFP to be translated as a separate peptide to avoid interference of Cas9 function. (b) Table of average frequencies of EGFP-expressing cells (transfection efficiencies) as determined by flow cytometry of triplicate samples for transfected Luc14, GAL4EED, and GAL4EED cells treated with doxycycline. (c) Mean editing frequencies normalized to transfection efficiency in Luc14, GAL4EED, or GAL4EED + dox cells for Cas9 targeted to sites sg046, sg055, sg032, sg034, sg054, sg031, sg025, sg044, and sg048. *Indicates significantly reduced editing efficiencies at fully silenced chromatin compared to unsilenced chromatin (p < 0.025 for 3 biological replicates). Editing frequencies for target sites sg046, sg055, sg032, and sg054 for both GAL4EED or GAL4EED + dox cell types were below detection limits. Error bars indicate s.d. for n = 3 biological replicates. (d) Summary of the data in (c). Cas9 target sites sg046, sg032, and sg054 show a reduction in editing efficiency in both the partially and fully silenced states compared to the unsilenced states (red arrows). Cas9 target sites sg034 and sg044 show a reduction in editing efficiency in the fully silence states compared to the unsilenced states (yellow arrows).
Article Snippet: Plasmid DNA Construction In order to determine transfection efficiencies using flow cytometry, we modified the vectors pX330-U6-Chimeric_BB-CBh-hSpCas9 4 (a gift from Feng Zhang, Addgene plasmid #42230) and pX330A_d-Cas9–1 × 4 [Nakagawa 2015] (a gift from Takashi Yamamoto, Addgene plasmid #63598) using the T2A peptide skipping sequence to express EGFP from the same mRNA transcript as the Cas9 protein.
Techniques: Expressing, Plasmid Preparation, Transfection, Flow Cytometry